Patents by Inventor Shu-Ping Hsueh

Shu-Ping Hsueh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metronomic oral gemcitabine for cancer therapy
    Patent number: 10835548
    Abstract: The disclosure relates to compositions and methods for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Use of gemcitabine, including in self-emulsifying orally administered dosage forms for these purposes is described. Gemcitabine is orally administered in a metronomic manner, which involves repeatedly administering a therapeutic amount of gemcitabine, being a fraction of the maximum tolerated dose, over an extended period of time, preferably on a non-interrupted schedule of weeks, months, or indefinitely.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: November 17, 2020
    Assignee: INNOPHARMAX, INC.
    Inventors: Wei-Hua Hao, Shu-Ping Hsueh, Chang-Shan Hsu
  • Metronomic Oral Gemcitabine for Cancer Therapy
    Publication number: 20170348341
    Abstract: The disclosure relates to compositions and methods for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Use of gemcitabine, including in self-emulsifying orally administered dosage forms for these purposes is described. Gemcitabine is orally administered in a metronomic manner, which involves repeatedly administering a therapeutic amount of gemcitabine, being a fraction of the maximum tolerated dose, over an extended period of time, preferably on a non-interrupted schedule of weeks, months, or indefinitely.
    Type: Application
    Filed: June 2, 2017
    Publication date: December 7, 2017
    Applicant: InnoPharmax, Inc.
    Inventors: Wei-Hua HAO, Shu-Ping Hsueh, Chang-Shan Hsu